Quick Summary
- Evercore ISI reduced Nike’s rating to In Line from Outperform, lowering the price target from $57 to $46
- Shares declined 1.4% in premarket hours Tuesday, starting trading at $43.22
- Primary issues include weakening U.S. retail channels, disappointing Jordan retro product launches, and delayed World Cup merchandise in European markets
- Evercore projects FY27 EPS at $1.65, significantly below the Street’s $1.82 consensus forecast
- The company recently surpassed earnings expectations ($0.35 actual vs $0.29 forecast) and offers a dividend yield of 3.8%
Shares of Nike (NKE) began Tuesday’s session at $43.22 following an Evercore ISI downgrade that dropped the athletic apparel giant from Outperform to In Line while reducing the price objective from $57 to $46. The stock had already declined 1.4% during premarket activity.
This rating reduction arrives approximately two years into the company’s restructuring initiative. According to Evercore’s latest channel checks, new indicators of vulnerability continue to emerge, and analysts are presenting a candid assessment.
Evercore identified three particular areas of concern. The first involves accelerating weakness across U.S. lifestyle and family retail segments, where order cancellations and delivery postponements exceed Nike‘s internal projections. The second relates to underperforming Jordan retro product releases. The third centers on European logistics challenges that resulted in delayed arrival of World Cup-related merchandise.
The firm lowered its fiscal 2027 earnings per share projection to $1.65 from $1.70 — notably beneath Wall Street’s $1.82 estimate. Its fiscal 2028 forecast also decreased to $2.20 from $2.25, compared to the consensus figure of $2.33.
Analyst Michael Binetti and his team cautioned that Nike might need to recalibrate Street expectations downward before its important Fall 2026 analyst presentation. Such a move, they suggested, would prove “highly distracting as it tries to refocus investors on a better narrative on that day.”
Market participants will monitor closely whether Nike adjusts its previous guidance indicating first-half fiscal 2027 revenue would drop in the low single-digit percentage range. Evercore anticipates minimal motivation for management to improve that forecast during the forthcoming quarterly earnings call.
Bright Spots Remain
The situation isn’t entirely negative. Evercore observed that athletic performance segments such as Nike Run continue demonstrating strength. Additionally, a possible $1 billion tariff reimbursement could provide resources for brand reinvestment.
Fourth-quarter consensus projections appear relatively secure. From a valuation perspective, the enterprise value-to-sales multiple of 1.5x has reached a 15-year trough, which Evercore indicated “could help backstop the stock from further meaningful downside.”
Nike’s latest quarterly earnings revealed $0.35 per share, exceeding the anticipated $0.29. Total revenue reached $11.28 billion, marginally above the projected $11.23 billion. Management also announced a $0.41 quarterly dividend per share, equating to a 3.8% annualized yield.
Insider and Institutional Activity Continues
Despite downward stock pressure, company insiders have been accumulating shares. Director Robert Holmes Swan purchased 11,781 shares at $42.44 during early April, while Director John W. Rogers Jr. acquired 4,000 shares at $43.34. Throughout the previous 90 days, insiders have accumulated 64,441 shares totaling more than $2.7 million.
Regarding institutional movement, SG Americas Securities expanded its Nike holdings by 14.5% during the first quarter, adding 167,301 shares to reach approximately 1.32 million shares valued around $69.7 million.
Broader analyst opinion has grown more cautious. The stock currently holds a consensus Hold recommendation with a mean price target of $60.89. HSBC reduced its target from $90 down to $48, while Royal Bank of Canada shifted from Outperform to Sector Perform with a $50 objective in early June.
Nike’s 12-month low stands at $41.35, with current trading levels hovering just above that floor.


